ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Scheduling for COVID-19 Updated Boosters for Children Ages Five and Older Now Available at Rite Aid and Bartell Drug Locations

Parents and guardians can visit Riteaid.com to schedule appointments for the updated booster as well as the flu shot; Health officials recommend getting up-to-date on COVID and Flu vaccinations by Halloween

Following FDA authorization and new CDC recommendations, Rite Aid (NYSE: RAD) locations, including Bartell Drugs in the Pacific Northwest, are now offering updated boosters of the Pfizer-BioNTech and Moderna COVID-19 vaccines for children ages five years and older.

Both vaccines require that it has been at least two months since completion of primary COVID vaccination series or since receiving most recent booster dose. The updated boosters are designed to protect against the original strains and Omicron BA.4 and BA.5 subvariants which are more transmissible and immune-evading. Parents or guardians can schedule eligible children using Rite Aid’s online scheduler at www.riteaid.com/pharmacy/scheduler. Bartell Drugs customers can use the online scheduling tool linked here.

“Approval of the updated booster for our pediatric population allows us to continue to help our communities fight COVID-19,” said Karen Staniforth, Chief Pharmacy Officer at Rite Aid. “This vaccine will help restore protection that has waned since the previous dose. With cooler weather upon us and people gathering more indoors, we urge our communities to stay up-to-date on their vaccines to protect themselves and others.”

Appointments are based on vaccine availability. Children must be accompanied by an adult to their vaccine appointment. Customers may receive their updated booster dose at Rite Aid or Bartell Drugs regardless of where they received their primary series or previous booster(s). Updated booster doses can be mixed and matched with primary vaccination series and previous boosters meaning customers can get either brand of the updated booster no matter which brand had been previously administered. Primary vaccination series are encouraged for customers, if not already received.

In addition to staying up to date on COVID-19 vaccinations, Rite also recommends customers schedule their flu shot which can be received at the same time as the updated COVID booster. The CDC recommends everyone six months of age and older receive a flu vaccine each season with rare exception, and this year the agency is encouraging everyone to get their vaccination by Halloween to be prepared for flu season.

About Rite Aid Corporation

Rite Aid is a full-service pharmacy that improves health outcomes. Rite Aid is defining the modern pharmacy by meeting customer needs with a wide range of vehicles that offer convenience, including retail and delivery pharmacy, as well as services offered through our wholly owned subsidiaries, Elixir, Bartell Drugs and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, consists of accredited mail and specialty pharmacies, prescription discount programs and an industry leading adjudication platform to offer superior member experience and cost savings. Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs has supported the health and wellness needs in the Seattle area for more than 130 years. Rite Aid employs more than 6,300 pharmacists and operates more than 2,300 retail pharmacy locations across 17 states. For more information, visit www.riteaid.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.83
+0.43 (0.17%)
AAPL  271.90
+2.47 (0.92%)
AMD  244.29
+0.31 (0.13%)
BAC  53.44
+0.02 (0.03%)
GOOG  290.08
-0.51 (-0.18%)
META  624.59
-7.17 (-1.14%)
MSFT  504.33
-1.67 (-0.33%)
NVDA  194.22
-4.83 (-2.43%)
ORCL  237.00
-3.83 (-1.59%)
TSLA  441.53
-3.70 (-0.83%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.